Delcath Systems, Inc. - Common Stock (DCTH)

A fundamental and technical analysis of (NASDAQ:DCTH): Why the high growth investor may take a look at DELCATH SYSTEMS INC (NASDAQ:DCTH).

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.

"Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, there's some big money down the road."

DCTH stock results show that Delcath Systems missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

These stocks are already showing gains this year, but they are all still affordable stocks ready to breakout.

Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York.

DCTH stock results show that Delcath Systems beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

DCTH stock results show that Delcath Systems beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.